Caffeine Sodium Benzoate for Electroconvulsive Therapy Augmentation

The Journal of ECT
Kevin M BozymskiEricka L Crouse

Abstract

Because of an ongoing manufacturer shortage of injectable caffeine sodium benzoate (CSB), patients at our health system were given CSB compounded in-house to increase seizure response during electroconvulsive therapy (ECT). Therefore, we aimed to evaluate its effectiveness and safety as an ECT augmentation agent. Medical records of patients who received compounded CSB at Virginia Commonwealth University Health System were reviewed to identify adults receiving it as part of an index ECT treatment course between June 2012 and December 2016. The primary outcome was change in electroencephalogram seizure duration from pre-caffeine session to initial caffeine session. Data were also collected on demographics, motor seizure duration, maximum heart rate, mean arterial pressure, and concurrent medication use for these sessions and the last caffeine session. Seven-one patients were included in the study, predominantly white females with a mean age of 58.6 years. The most common indication for ECT was major depressive disorder resistant to pharmacotherapy (71.8%), followed by catatonia associated with another mental disorder (19.7%). Electroencephalogram seizure duration increased by 24.1 seconds on average with first CSB use (P < 0.0001...Continue Reading

References

Jan 1, 1992·The American Journal of Psychiatry·R J Ancill, W Carlyle
May 1, 1990·The American Journal of Psychiatry·C E CoffeyW B Saunders
Apr 1, 1988·The American Journal of Psychiatry·A G Acevedo, J K Smith
May 1, 1987·Biological Psychiatry·C E CoffeyW H Wilson
Sep 1, 1987·The American Journal of Psychiatry·P E HinkleC Christison
Sep 1, 1987·The American Journal of Psychiatry·B ShapiraA Calev
Jul 1, 1995·Journal of Geriatric Psychiatry and Neurology·M C Kelsey, G T Grossberg
Oct 1, 1993·The American Journal of Psychiatry·W V McCallN Kiesow-Webb
Oct 24, 2002·The Journal of ECT·Catherine DattoStanley N Caroff
Aug 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Harold A SackeimMark Olfson
Nov 9, 2007·The New England Journal of Medicine·Sarah H Lisanby
Nov 11, 2008·The Journal of ECT·William L CuaJonathan T Stewart
Jun 22, 2010·The Journal of ECT·Charles H KellnerJessica Wiegand
Jun 22, 2010·The Journal of ECT·Colleen LooRoss MacPherson
Oct 11, 2011·The Journal of ECT·Rafael Euba
Jun 30, 2016·Trends in psychiatry and psychotherapy·Orlando von DoellingerJoão Coelho Silva
Apr 14, 2017·International Review of Psychiatry·Richard D Weiner, Irving M Reti
Jun 2, 2017·The Journal of ECT·Christopher R TakalaBrian A Palmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Catatonia

Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.